IH

iHuman Inc.
$1.21
+0.01 (+0.42%)
Mkt Cap 12.34M
Volume 3,887
52W Range 1.2-3.164
Sector Consumer Defensive
Beta 0.13
EPS (TTM) 1.06 USD
P/E Ratio 1.13
Revenue (TTM) 116.15M USD
Rev Growth (5Y) +8.7%
EPS Growth (5Y) N/A
AlphaQuality · Grade
How strong & durable the business is
B
Stable Earnings Power
72.5 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018
Revenue 807.02M 922.20M 1.02B 985.52M 944.72M 531.91M 218.66M 131.87M
Net Income 95.40M 98.59M 180.91M 109.82M (37.05M) (37.48M) (275.60M) (17.60M)
EPS 9.10 9.40 17.15 10.30 -3.45 -5.35 -25.85 -1.72
Free Cash Flow 45.15M 51.10M 165.61M 1.25B 5.93M 207.08M 40.24M (5.03M)
FCF / Share 4.39 4.88 15.68 116.89 0.56 22.87 3.77 -0.47
Operating CF 49.92M 58.55M 172.12M 1.29B 38.21M 222.99M 42.63M (4.50M)
Total Assets 1.37B 1.42B 1.45B 1.33B 1.10B 1.05B 168.31M 58.60M
Total Debt 11.38M 14.91M 3.86M 9.02M 34.25M 6.61M 0 61.82M
Cash & Equiv 1.15B 1.12B 1.21B 1.05B 855.36M 861.68M 104.88M 6.12M
Book Value 995.80M 960.85M 957.80M 769.45M 608.37M 642.65M (14.45M) (63.73M)
Return on Equity 0.10 0.10 0.19 0.14 -0.06 -0.06 N/A N/A
IH News
ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
Aug 23, 2026 11:00 PM · gurufocus.com
iHuman Inc. Announces First Quarter 2026 Unaudited Financial Results
Jun 29, 2026 04:54 AM · prnewswire.com
Jazz Pharmaceuticals Delivers Extensive Late-Breaking Data at SLEEP 2026, Demonstrating Real-World Impact of Xywav® (calcium, magnesium, potassium, and sodium oxybates) on Patient Outcomes Across Narcolepsy and Idiopathic Hypersomnia
Jun 16, 2026 12:05 PM · prnewswire.com
iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo
May 31, 2026 09:00 AM · gurufocus.com
iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo
May 31, 2026 08:03 AM · prnewswire.com
iHuman Inc. Files 2025 Annual Report on Form 20-F
Apr 24, 2026 12:23 PM · prnewswire.com
iHuman Inc. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results
Mar 31, 2026 02:06 AM · prnewswire.com